Germline testing of BRCA1 , BRCA2 , PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM , RAD51C and RAD51D in over 400.
Emma Roisin WoodwardFiona LallooClaire FordeSarah PughGeorge Joseph BurghelHelene SchlechtElaine F HarknessAnthony HowellSacha J HowellAshu GandhiD Gareth EvansPublished in: Journal of medical genetics (2024)
PGVs.